GENETIC EPIDEMIOLOGY OF BLOOD PRESSURE RESPONSE TO ANGIOTENSIN RECEPTOR BLOCKER

血管紧张素受体阻滞剂血压反应的遗传流行病学

• 批准号: 7376428
• 负责人: ARLENE B CHAPMAN
• 金额: $ 8.8万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7376428
• 关键词: GENETIC; EPIDEMIOLOGY; BLOOD; PRESSURE; RESPONSE

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Variation in candidate genes, considered as one or in combination, makes no contribution to the prediction of blood pressure response to hydrochlorothiazide or an angiotensin receptor blocker before or after considering variation in confounders including gender, age, body size, and measures of the renin angiotensin-aldosterone system.

这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金，因此可能会出现在其他CRISE条目中。列出的机构是针对中心的，而不一定是针对调查员的机构。在考虑性别、年龄、体型和肾素血管紧张素-醛固酮系统的测量的混杂因素的变化之前或之后，候选基因的变异，被认为是一个或联合的，对预测氢氯噻嗪或血管紧张素受体阻滞剂的血压反应没有贡献。